Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07524218 · ClinicalTrials.gov registry record · NA
Effect of Meal Timing During Adjuvant Treatment for Cancer
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07524218 is a NA study that has not yet begun recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 50 participants.
The verdict
NCT07524218, a NA study, has not yet begun recruiting, sponsored by Fred Hutchinson Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test meal-timing as a novel and sustainable interventional approach during cancer treatment to improve therapeutic response, patient well-being and long-term metabolic health. In alignment with these priorities, we propose to focus on patients with histologically or cytologically confirmed solid tumors treated with curative-intent surgical resection and planned initiation of systemic adjuvant therapy (chemotherapy, targeted therapy, immunotherapy, and/or radiation per standard of care). A promising strategy for improving the efficacy of anticancer treatments and reducing associated toxicities involves combining treatment with fasting regimens. In pre-clinical and clinical studies, various forms of fasting have been shown to induce tumor regression and improve long-term survival. According to the differential stress sensitization theory, fasting is thought to sensitize tumor cells to the cytotoxic effects of chemotherapy and radiation, while protecting healthy cells by increasing stress resistance. While healthy cells slow their growth and become more stress resistant in response to fasting, cancer cells cannot survive in nutrient-deficient environments; although the underlying mechanisms are not fully understood. However, extended water-only fasting can be challenging for patients and poses undue health risks. Intermittent fasting, and specifically time-restricted eating (TRE), may offer a viable alternative. TRE involves eating within a shorter window (e.g., 8 hours) and fasting for the remainder of the day but involves no other dietary restrictions. Because of its simplicity, TRE may be more sustainable than other fasting regimens. TRE also improves several cardio-metabolic endpoints, including insulin sensitivity, which may also be beneficial during anticancer treatments.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Questionnaire Administration
- BEHAVIORAL Time-restricted eating
- BEHAVIORAL Health coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-06 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07524218
The ClinicalTrials.gov registry entry for NCT07524218 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT07524218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07524218 about?
NCT07524218 is a clinical study titled "Effect of Meal Timing During Adjuvant Treatment for Cancer". The goal of this clinical trial is to test meal-timing as a novel and sustainable interventional approach during cancer treatment to improve therapeutic response, patient well-being and long-term metabolic health. In alignment with these priorities, we propose to focus on patients with histologicall...
What is the current status of trial NCT07524218?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-06. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT07524218?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Time-restricted eating (BEHAVIORAL), Health coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT07524218?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.